|
Job Opportunity: Tech Scout, Associate
|
|
0
|
11
|
February 1, 2023
|
|
Funding Opportunity for Molecular TB Assay Developers
|
|
0
|
14
|
February 1, 2023
|
|
Development of Swab-Based TB Assays on Point-of-Care Molecular Platform
|
|
0
|
10
|
January 31, 2023
|
|
The integration of tuberculosis and HIV testing on GeneXpert can substantially improve access and same-day diagnosis and benefit tuberculosis programmes
|
|
0
|
24
|
January 26, 2023
|
|
Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis
|
|
0
|
17
|
January 20, 2023
|
|
The 2nd International Post-Tuberculosis Symposium
|
|
0
|
23
|
January 9, 2023
|
|
Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study
|
|
0
|
37
|
December 17, 2022
|
|
Impact of molecular diagnostic tests on diagnostic and treatment delays in tuberculosis: a systematic review and meta-analysis
|
|
0
|
95
|
December 14, 2022
|
|
Special issue of Lab Culture: Expanding the diagnostic toolkit for tracking Mycobacterium tuberculosis
|
|
0
|
139
|
November 23, 2022
|
|
TAG Launches 2022 TB Diagnostics Pipeline Report
|
|
0
|
196
|
November 11, 2022
|
|
The COugh Diagnostic Algorithm for Tuberculosis (CODA TB) DREAM Challenge
|
|
0
|
269
|
October 27, 2022
|
|
Tb diagnostics webinar: where do we go from here?
|
|
0
|
197
|
October 5, 2022
|
|
Deep Learning Detection of Active Pulmonary Tuberculosis at Chest Radiography Matched the Clinical Performance of Radiologists
|
|
0
|
181
|
September 10, 2022
|
|
Strengthening resistance testing for tuberculosis in India
|
|
0
|
282
|
August 10, 2022
|
|
Making cough count in tuberculosis care
|
|
0
|
301
|
July 8, 2022
|
|
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
|
|
0
|
310
|
May 20, 2022
|
|
TB laboratory manuals issued to support the implementation of WHO-recommended diagnostics
|
|
0
|
328
|
May 13, 2022
|
|
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views
|
|
0
|
321
|
April 27, 2022
|
|
Community-led Monitoring for Access to Tuberculosis Screening and Diagnostic Testing
|
|
0
|
307
|
April 20, 2022
|
|
Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all?
|
|
0
|
301
|
March 26, 2022
|
|
MSF blog: The deadly gap in diagnosing children with tuberculosis
|
|
0
|
356
|
March 26, 2022
|
|
Integrated testing for tuberculosis & Covid-19
|
|
0
|
324
|
March 3, 2022
|
|
Use of alternative interferon-gamma release assays for the diagnosis of TB infection - WHO Policy Statement
|
|
0
|
367
|
January 28, 2022
|
|
Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay
|
|
0
|
351
|
January 27, 2022
|
|
Covid-19’s devastating impact on tuberculosis care
|
|
0
|
345
|
January 6, 2022
|
|
Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis
|
|
0
|
356
|
December 28, 2021
|
|
Stop TB Vacancy Announcement: diagnostics project officer
|
|
0
|
465
|
December 1, 2021
|
|
Available Now: TAG's 2021 TB Pipeline Report Chapters
|
|
0
|
383
|
December 1, 2021
|
|
TB epidemiologist position at Heidelberg
|
|
0
|
276
|
November 24, 2021
|
|
Webinar: Test and Treat the Drug Resistant TB
|
|
0
|
387
|
October 20, 2021
|